|
USP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.298200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.852250E-01 |
| Normal-vs-Stage2 |
8.154800E-04 |
| Normal-vs-Stage3 |
1.464840E-01 |
| Normal-vs-Stage4 |
4.099600E-01 |
| Stage1-vs-Stage2 |
4.558500E-03 |
| Stage1-vs-Stage3 |
7.253600E-01 |
| Stage1-vs-Stage4 |
8.452800E-01 |
| Stage2-vs-Stage3 |
1.151820E-02 |
| Stage2-vs-Stage4 |
6.963500E-03 |
| Stage3-vs-Stage4 |
6.492600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.004100E-02 |
| Normal-vs-AfricanAmerican |
5.038200E-03 |
| Normal-vs-Asian |
3.948200E-01 |
| Caucasian-vs-AfricanAmerican |
6.164300E-02 |
| Caucasian-vs-Asian |
7.152000E-01 |
| AfricanAmerican-vs-Asian |
9.080100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.758200E-01 |
| Normal-vs-Female |
2.187900E-02 |
| Male-vs-Female |
1.885210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.499000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.527800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.190500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.222200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.683000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.672780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.283600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.754000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.727200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.559400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.245700E-02 |
| Classical-VS-Follicular |
4.695000E-01 |
| Classical-VS-Other |
4.242600E-03 |
| Classical-VS-Normal |
1.081830E-02 |
| Tall-VS-Follicular |
4.986200E-01 |
| Tall-VS-Other |
1.258410E-02 |
| Tall-VS-Normal |
7.033400E-01 |
| Follicular-VS-Other |
6.417900E-02 |
| Follicular-VS-Normal |
2.716400E-01 |
| Other-VS-Normal |
1.552220E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.920800E-03 |
| Normal-vs-N1 |
8.305700E-02 |
| N0-vs-N1 |
1.630030E-04 |
|
|
